BRIEF DESCRIPTION OF THE DRAWINGS
The following drawings are provided.
FIG. 1 shows behavior of Compound I (commercial compound HYPERFORM® HPN-68L) when combined with another nucleating agent sodium benzoate;
FIG. 2 illustrates plaque shrinkage behavior using blends of the invention;
FIG. 3 reveals shrinkage data for blends of Compound I and Compound II at 500 ppm in homopolymer;
FIG. 4 shows shrinkage data for blends of Compound I and Compound II at 1000 ppm in homopolymer;
FIG. 5 shows half time data for such blends;
FIG. 6 shows additional shrinkage data;
FIG. 7 illustrates Tc data for various blends at different concentration levels;
FIG. 8 illustrates flexural modulus data;
FIG. 9 indicates shrinkage data for such blends; and
FIG. 10 provides further shrinkage data at different loading levels.